3. GOODCHILD - intranasal ketamine ANZCA FPM spring 2009.pdf
3. GOODCHILD - intranasal ketamine ANZCA FPM spring 2009.pdf
3. GOODCHILD - intranasal ketamine ANZCA FPM spring 2009.pdf
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
• study performed in adults<br />
• 25 mg racemic <strong>ketamine</strong> <strong>intranasal</strong>ly<br />
• samples @ 5, 10, 20, 30 minutes post dose – 20 ng/ml at 5 mins<br />
• 45% bio-availability